Citadel Advisors’s First Trust Indxx Medical Devices ETF MDEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,130
Closed -$238K 14964
2024
Q1
$238K Buy
+11,130
New +$230K ﹤0.01% 9959
2023
Q2
Sell
-11,796
Closed -$240K 14880
2023
Q1
$240K Sell
11,796
-440
-4% -$8.69K ﹤0.01% 9839
2022
Q4
$230K Sell
12,236
-6,543
-35% -$117K ﹤0.01% 9859
2022
Q3
$306K Sell
18,779
-11
-0.1% -$204 ﹤0.01% 9536
2022
Q2
$341K Sell
18,790
-419
-2% -$8.28K ﹤0.01% 9520
2022
Q1
$432K Buy
19,209
+6,563
+52% +$148K ﹤0.01% 9736
2021
Q4
$333K Buy
+12,646
New +$327K ﹤0.01% 10694

Other funds holding MDEV

Citadel Advisors's MDEV Position: Q2 2024 in Review

Citadel Advisors sold out of First Trust Indxx Medical Devices ETF (MDEV) in Q2 2024, closing a stake of 11,130 shares — an estimated $238K sold.

Citadel Advisors first reported a position in MDEV in Q4 2021 and held it in 7 quarters. The position peaked at $432K in Q1 2022. 7 funds tracked by Wall St. Rank hold MDEV as of Q2 2024.

  • Citadel Advisors reported no remaining First Trust Indxx Medical Devices ETF position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 11,130 First Trust Indxx Medical Devices ETF shares in Q2 2024, an estimated $238K.
  • Citadel Advisors first reported a position in First Trust Indxx Medical Devices ETF in Q4 2021 and held it in 7 quarters.
  • Citadel Advisors's First Trust Indxx Medical Devices ETF position peaked at $432K in Q1 2022.
  • 7 funds tracked by Wall St. Rank held First Trust Indxx Medical Devices ETF as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.